BioStock: Respiratorius gets patent approval in Brazil for VAL001
Barely a month ago, Respiratorius received a patent approval in the EU for its RESP9000 series of drug candidates. Now it is announcing further patent news in the form of an approval in Brazil, this time for the drug candidate VAL001. With this approval, the candidate will be given market exclusivity in Brazil until 2031.
Read the full article at biostock.se:
https://www.biostock.se/en/2021/10/respiratorius-gets-patent-approval-in-brazil-for-val001/
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se